EG 427 recognised in iLab 2020
EG 427 is one of the laureate of the innovation contest iLab 2020 and received non dilutive funding from Bpifrance to support its innovative preclinical program of gene therapy in the treatment of neurogenic bladder.
EG 427 is one of the laureate of the innovation contest iLab 2020 and received non dilutive funding from Bpifrance to support its innovative preclinical program of gene therapy in the treatment of neurogenic bladder.